Abstract
The term macrolide has been applied to members of a group of structurally related antibiotics produced by species of streptomyces. All macrolide antibiotics (Woodward, 1957) contain a large lactone ring (aglycone of 12 to 22 atoms) which contain few double bonds and no nitrogen atoms; they have one or more sugars which can be amino sugars, non-nitrogenous sugars or both. In the widest sense however, the term macrolide has been ascribed to all the antibiotics containing a large lactone ring; in this sense the polyene antibiotic and antibiotics of streptogramin A and streptogramin B groups can be also termed macrolides. This article will be restricted to the “classical” macrolides of Woodward (1957) and related compounds discovered after 1957.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anliker, R., u. K. Gubler: Stoffwechselprodukte von Actinomyceten. Die Konstitution des Kromycins ein Abbauprodukt des Pikromycins. Hely. Chim. Acta 40, 1768 (1957).
Brock, T. D., and M. L. Brock: Similarity in mode of action of chloramphenicol and erythromycin. Biochim. et Biophys. Acta 33, 274 (1959).
Brockmann, H., u. W. Henkel: Pikromycin ein neues Antibiotikum aus Actinomyceten. Naturwissenschaften 37, 138 (1950).
Brockmann, H., u. R. Oster: Antibiotica aus Actinomyceten. Xxxviii. Zur Konstitution des Pikromycins und Kromycins (Pikromycin, VI). Chem. Ber. 90, 605 (1957).
Celmer, W. D.: Macrolide stereochemistry. I. The total absolute configuration of oleandomycin. J. Am. Chem. Soc. 87, 1797 (1965a).
Celmer, W. D.: Macrolide stereochemistry. II. Configurational assignments at certain centers in various macrolide antibiotics. J. Am. Chem. Soc. 87, 1799 (1965b).
Celmer, W. D.: A configurational model for macrolide antibiotics. J. Am. Chem. Soc. 87, 1801 (1965c).
Celmer, W. D.: Basic stereochemical research topics in the macrolide antibiotics. In: Biogenesis of antibiotic substances, ed by Z. VanÉK and Z. HosTÄLÉK. New-York and London: Academic Press 1965c.
Chabbert, Y.: Antagonisme in vitro entre l’erythromycine et la spiramycine. Ann. Inst. Pasteur 90, 787 (1956).
Corbaz, R., L. Ettlinger, E. GÄUmann, W. Keller-Schierlein, L. Neipp, V. Prelog, P. Reusser u. H. ZÄHner: Stoffwechselprodukte von Actinomyceten. Angolamycin. Helv. Chim. Acta 38, 1202 (1955).
Coleman, V. R., J. B. Gunnison, and E. Jawetz: Participation of erythromycin and carbomycin in combined antibiotic action in vitro. Proc. Soc. Exptl. Biol. Med. 83, 668 (1953).
Djerassi, C., and O. Halpern: Macrolide antibiotics. Vii. The structure of neomethymycin. Tetrahedron 3, 255 (1958).
Djerassi, C., and J. A. Zderic: The structure of the antibiotic methymycin. J. Am. Chem. Soc. 78, 6390 (1956).
Donin, M. N., J. Pagano, J. D. Dutcher, and C. M. Mckee: Methymycin, a new crystalline antibiotic. Antibiotics Ann. 1953/54, 179.
English, A. R., M. F. Field, S. R. Szendy, N. J. Tagliani, and R. A. Fitts: Magnamycin. I. In vitro studies. Antibiotics Chemotherapy 2, 678 (1952).
Finland, M., C. Wilcox, and E. M. Purcell: Cross resistance to antibiotics: Effect of exposures of bacteria to carbomycin or erythromycin in vivo. Proc. Soc. Exptl. Biol. Med. 81, 725 (1952).
FusIllo, M. H., H. E. NoYes, E. J. Pulaski, and J. Y. S. ToM: Antimicrobial spectrum and cross resistance studies of erythromycin and carbomycin. Antibiotics Chemotherapy 3, 581 (1953).
Gardocki, J. F., S. Y. P’AN, A. L. Rapuzzi, G. M. Fanelli, and E. K. Timmens: Magnamycin: toxicity in experimental animals Antibiotics Chemotherapy 3, 55 (1953).
Garrod, L. P., and P. M. Waterworth: Behaviour in vitro of some new antistaphylococcal antibiotics. Brit. Med. J. 1956, II 61.
Gastal, R.: Action de la spiramycine sur l’infection expérimentale de la souris par H. pertussis. Ann. Inst. Pasteur 94, 636 (1958).
GÄUmann, E., R. HÜTter, W. Keller-Schierlein, L. Neipp, V. Prelog u. H. ZÄHner: Stoffwechselprodukte von Actinomyceten. Rely. Chim. Acta 43, 601 (1960).
Hochstein, F. A., and K. Murai: Magnamycin B, a second antibiotic from Streptomyces halstedii. J. Am. Chem. Soc. 76, 5080 (1954).
HsIE, J.-Y., R. Kotz, and W. Nusser: Analysis of cross resistance to erythromycin and carbomycin in Micrococcus pyogenes var. aureus. Antibiotics Ann. 1955/56, 773.
Hudson, D. G., G. M. Yoshihara, and W. M. M. Kirby: Spiramycin. Clinical and laboratory studies. A.M.A. Arch. Internal Med. 97, 57 (1956).
Jones, W. F., R. L. Nichols, and M. Finland: Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin. Proc. Soc. Exptl. Biol. Med. 93, 388 (1956).
Jordan, D. C.: Effect of chalcomycin on protein synthesis by Staphylococcus aureus. Can. J. Microbiol. 9, 129 (1929).
Lutz, A., O. Grooten et J. Hofferer: Evolution et modifications de la résistance des staphylocoques pathogènes à six antibiotiques usuels de 1950 à 1956. L’action comparée in vitro de l’érythromycine, de la magnamycine, de la spiramycine, de la novobiocine (albamycine) et de l’oléandomycine. Ann. Inst. Pasteur 92, 778 (1957).
Maniar, A. C., et L. Eidus: Un des facteurs influençant l’action des antibiotiques. Ann. Inst. Pasteur 101, 887 (1961).
Mathieu, N., et M. Faguet: Activité in vitro de la spiramycine en association avcc la tétracycline, l’érythromycine, la pénicilline, la streptomycine sur la multiplication de Staphylococcus aureus étudiée au microbiophotomètre. Ann. Inst. Pasteur 94, 69 (1958).
Miyake, A., H. Iwasaki, T. Takewata, M. Shibata, and K. Nakazawa: Production of tertiomycin A by Streptomyces albireticuli. J. Antibiotics (Japan), Ser. A 12, 59 (1959).
Morin, R. B., and M. Gorman: The partial structure of tylosin, a macrolide antibiotic. Tetrahedron Letters, p. 2339 (1964).
Pagano, J. F., M. J. Weinstein, and C. M. McKee: An anti-rickettsial antibiotic from a streptomycete, M-4209. I. Biological caracterizations. Antibiotics Chemotherapy 3, 899 (1953).
Paul, R., et S. Tchelitcheff: Structure de la spiramycine. VI. Etablissement de la formule développée. Bull. soc. chim. France, p. 650 (1965).
Pinnert-Sindico, S., L. Ninet, J. Preud’Homme, and C. Cosar: A new antibiotic, spiramycin. Antibiotics Ann. 1954/55, 724.
Prelog, V., A. M. Gold, G. Talbot H. A. Zamojski: Stoffwechselprodukte von Actinomyceten. Über die Konstitution der Narbomycins. Hely. Chim. Acta 45, 4 (1962).
Seneca, H., and D. Ides: The effect of magnamycin on protozoa and spermatozoa. Antibiotics Chemotherapy 3, 117 (1953).
Suzuka, I., H. Kaji, and A. Kaji: Binding of specific Rna to 30 S subunits. Comparison with the binding to 70 s ribosomes. Biochem. Biophys. Research Commun. 21, 187 (1965).
Tanner, F. W., A. R. English, T. M. Lees, and J. B. Routien: Some properties of magnamycin, a new antibiotic. Antibiotics Chemotherapy 2, 441 (1952).
Taubman, S. B., F. E. Young, and J. W. Corcoran: Antibiotic glycosides. IV. Studies on the mechanism of erythromycin resistance in Bacillus subtilis. Proc. Natl. Acad. Sci. U.S. 50, 955 (1963).
Umezawa, H.: Recent advances in chemistry and biochemistry of antibiotics. Tokyo 1964. Microbial Chemistry Research Foundation.
Vazquez, D.: The binding of chloramphenicol by ribosomes from Bacillus megaterium. Biochem. Biophys. Research Commun. 15, 464 (1964).
Vazquez, D.: Binding of chloramphenicol to ribosomes. The effect of a number of antibiotics. Biochim. et Biophys. Acta 144, 277 (1966a).
VazquEZ, D.: Antibiotics affecting chloramphenicol uptake by bacteria. Their effect on amino acid incorporation in a cell-free system. Biochim. et Biophys. Acta 114, 289 (1966b).
Videau, D.: Sur le mode d’action des antibiotiques. Cas particulier de la spiramycine. Ann. Inst. Pasteur 94, 709 (1958).
Watanabe, T.: Studies on leucomycin. IV. Isolation of mycaminose from the acid hydrolysate. Bull. Chem. Soc. Japan 34, 15 (1961).
Watanabe, T., H. Nishida, J. Abe, and K. Satake: Studies on leucomycin. Bull. Chem. Soc. Japan 33, 1104 (1960).
Wong, S. C., C. C. James, and A. Finlay: The action of carbomycin (magnamycin) on some viral and rickettsial infectial infections. Antibiotics Chemotherapy 3, 741 (1953).
Woodward, R. B.: Struktur und Biogenese der Makrolide. Eine neue Klasse von Naturstoffen. Angew. Chem. 69, 50 (1957).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1967 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vazquez, D. (1967). Macrolide antibiotics — Spiramycin, Carbomycin, Angolamycin, Methymycin and Lancamycin. In: Gottlieb, D., Shaw, P.D. (eds) Antibiotics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-38439-8_25
Download citation
DOI: https://doi.org/10.1007/978-3-662-38439-8_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-37649-2
Online ISBN: 978-3-662-38439-8
eBook Packages: Springer Book Archive